ArticleExperimental and therapeutic medicine2020

Response gene to complement-32 promotes cell survival via the NF-κB pathway in non-small-cell lung cancer.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.